The IBC is responsible for reviewing projects in which biohazards are used ensuring that research is conducted safely and that risks are assessed and minimized – see IBC Charge. The IBC reviews and approves projects and issues Biohazard Use Authorization (BUA) permits per the standard operating procedure: SOP IBC BUA Review and Approval Process. Visit the Biohazard Use Authorization (BUA) web page to register, renew, or amend a BUA.
Additionally, Human Gene Transfer (HGT) clinical trials need to be reviewed by an IBC. Before HGT clinical trials can commence, the study teams need to fulfill a specific set of requirements before they can be approved by the IBC. Read more about the IBC approval process for HGT clinical trials.
IBC Deadlines and Meeting Dates
| Protocol Submission Deadline | IBC Meeting Dates | Zoom |
|---|---|---|
| January 4, 2024 | January 25, 2024 | Zoom>> |
| February 8, 2024 | February 29, 2024 | SBA 329 or Zoom>> |
| March 7, 2024 | March 28, 2024 | Zoom>> |
| April 4, 2024 | April 25, 2024 | Zoom>> |
| May 9, 2024 | May 30, 2024 | SBA 329 or Zoom>> |
| June 6, 2023 | June 27, 2024 | Zoom>> |
| – | July 25, 2024 | Zoom>> |
| August 8, 2024 | August 29, 2024 | SBA 329 or Zoom>> |
| September 5, 2024 | September 26, 2024 | Zoom>> |
| October 10, 2024 | October 31, 2024 | Zoom>> |
| October 31, 2024 | November 21, 2024 | SBA 329 or Zoom>> |
| – | December 19, 2024 | Zoom>> |